Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000400310 | SCV000336712 | uncertain significance | not provided | 2015-11-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001084533 | SCV000561351 | likely benign | Familial hypocalciuric hypercalcemia; Autosomal dominant hypocalcemia 1 | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004021153 | SCV001180031 | likely benign | Nephrolithiasis/nephrocalcinosis | 2019-10-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |